Evogene Market Cap

Evogene has a market cap or net worth of 39.79 million as of June 27, 2025. Its market cap has decreased by -69.02% in one year.

Market Cap

39.79M

Enterprise Value

72.49M

Revenue

25.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

457.30

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 39.79M, a decrease of -64.83%. That is a compound annual growth rate of -5.73%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	39.79M	-15.98%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	66.47B
Danel (Adir Yeoshua)	2.80B
Kamada	1.53B
Bait Bakfar	1.06B
BrainsWay	801.90M
Novolog (Pharm-Up 1966)	722.84M
Ilex Medical	719.95M
SofWave Medical	713.46M

Market Cap Rankings